RWD170 Real-World Experience of Patients Newly Initiated on Pexidartinib for Tenosynovial Giant Cell Tumor
Jun 1, 2024, 00:00 AM
10.1016/j.jval.2024.03.2467
https://www.valueinhealthjournal.com/article/S1098-3015(24)02681-0/fulltext
Section Title :
Section Order :
11477
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)02681-0&doi=10.1016/j.jval.2024.03.2467